Notch signaling: switching an oncogene to a tumor suppressor
- PMID: 24608975
- PMCID: PMC3990910
- DOI: 10.1182/blood-2013-08-355818
Notch signaling: switching an oncogene to a tumor suppressor
Abstract
The Notch signaling pathway is a regulator of self-renewal and differentiation in several tissues and cell types. Notch is a binary cell-fate determinant, and its hyperactivation has been implicated as oncogenic in several cancers including breast cancer and T-cell acute lymphoblastic leukemia (T-ALL). Recently, several studies also unraveled tumor-suppressor roles for Notch signaling in different tissues, including tissues where it was before recognized as an oncogene in specific lineages. Whereas involvement of Notch as an oncogene in several lymphoid malignancies (T-ALL, B-chronic lymphocytic leukemia, splenic marginal zone lymphoma) is well characterized, there is growing evidence involving Notch signaling as a tumor suppressor in myeloid malignancies. It therefore appears that Notch signaling pathway's oncogenic or tumor-suppressor abilities are highly context dependent. In this review, we summarize and discuss latest advances in the understanding of this dual role in hematopoiesis and the possible consequences for the treatment of hematologic malignancies.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3990910/bin/2451f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3990910/bin/2451f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3990910/bin/2451f3.gif)
Similar articles
-
Role of Notch Receptors in Hematologic Malignancies.Cells. 2020 Dec 24;10(1):16. doi: 10.3390/cells10010016. Cells. 2020. PMID: 33374160 Free PMC article. Review.
-
The role of Notch in tumorigenesis: oncogene or tumour suppressor?Nat Rev Cancer. 2003 Oct;3(10):756-67. doi: 10.1038/nrc1186. Nat Rev Cancer. 2003. PMID: 14570040 Review.
-
Oncogenic and Tumor-Suppressive Functions of NOTCH Signaling in Glioma.Cells. 2020 Oct 15;9(10):2304. doi: 10.3390/cells9102304. Cells. 2020. PMID: 33076453 Free PMC article. Review.
-
Notch signaling: its roles and therapeutic potential in hematological malignancies.Oncotarget. 2016 May 17;7(20):29804-23. doi: 10.18632/oncotarget.7772. Oncotarget. 2016. PMID: 26934331 Free PMC article. Review.
-
Notch-ing from T-cell to B-cell lymphoid malignancies.Cancer Lett. 2011 Sep 1;308(1):1-13. doi: 10.1016/j.canlet.2011.05.009. Cancer Lett. 2011. PMID: 21652011 Review.
Cited by
-
Enhancer-driven gene regulatory networks inference from single-cell RNA-seq and ATAC-seq data.Brief Bioinform. 2024 Jul 25;25(5):bbae369. doi: 10.1093/bib/bbae369. Brief Bioinform. 2024. PMID: 39082647 Free PMC article.
-
Dysregulated gene subnetworks in breast invasive carcinoma reveal novel tumor suppressor genes.Sci Rep. 2024 Jul 8;14(1):15691. doi: 10.1038/s41598-024-59953-0. Sci Rep. 2024. PMID: 38977697 Free PMC article.
-
Inhibition of NOTCH4 sensitizes FLT3/ITD acute myeloid leukemia cells to FLT3 tyrosine kinase inhibition.Leukemia. 2024 Jul;38(7):1581-1591. doi: 10.1038/s41375-024-02292-w. Epub 2024 May 29. Leukemia. 2024. PMID: 38811818
-
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies.Signal Transduct Target Ther. 2024 May 27;9(1):128. doi: 10.1038/s41392-024-01828-x. Signal Transduct Target Ther. 2024. PMID: 38797752 Free PMC article. Review.
-
Cell of origin epigenetic priming determines susceptibility to Tet2 mutation.Nat Commun. 2024 May 21;15(1):4325. doi: 10.1038/s41467-024-48508-6. Nat Commun. 2024. PMID: 38773071 Free PMC article.
References
-
- Nicolas M, Wolfer A, Raj K, et al. Notch1 functions as a tumor suppressor in mouse skin. Nat Genet. 2003;33(3):416–421. - PubMed
-
- Morgan TH. The theory of the gene. Am Nat. 1917;51:513–514.
-
- Wharton KA, Johansen KM, Xu T, Artavanis-Tsakonas S. Nucleotide sequence from the neurogenic locus notch implies a gene product that shares homology with proteins containing EGF-like repeats. Cell. 1985;43(3 Pt 2):567–581. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA105129/CA/NCI NIH HHS/United States
- 5P01CA109901/CA/NCI NIH HHS/United States
- 1R01CA176746/CA/NCI NIH HHS/United States
- R01CA173636/CA/NCI NIH HHS/United States
- R01 CA169784/CA/NCI NIH HHS/United States
- R21 CA141399/CA/NCI NIH HHS/United States
- R01CA149655/CA/NCI NIH HHS/United States
- G0500389/MRC_/Medical Research Council/United Kingdom
- R01 CA173636/CA/NCI NIH HHS/United States
- P01 CA109901/CA/NCI NIH HHS/United States
- R01 CA133379/CA/NCI NIH HHS/United States
- R01CA133379/CA/NCI NIH HHS/United States
- R01 CA176746/CA/NCI NIH HHS/United States
- T32 GM007308/GM/NIGMS NIH HHS/United States
- R01 CA149655/CA/NCI NIH HHS/United States
- P30 CA006516/CA/NCI NIH HHS/United States
- R01CA105129/CA/NCI NIH HHS/United States
- P30CA06516/CA/NCI NIH HHS/United States
- HHMI/Howard Hughes Medical Institute/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources